A recurrent de novo MAX p.Arg60Gln variant causes a syndromic overgrowth disorder through differential expression of

Erica L Harris1, Vincent Roy2, Martin Montagne2

  • 1Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.

PubMed

Insights

A novel Myc-associated factor X (MAX) gene variant causes macrocephaly by increasing cyclin D2 (CCND2) transcription. This MAX mutation enhances c-Myc activity, suggesting a therapeutic target for related disorders.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • Macrocephaly disorders are often linked to Cyclin D2 (CCND2) stabilization.
  • Mutations in CCND2 or the PI3K-AKT pathway are common causes.

Purpose of the Study:

  • Investigate the genetic basis of macrocephaly in three individuals with overlapping phenotypes.
  • Characterize a novel de novo variant in the Myc-associated factor X (MAX) gene.

Main Methods:

  • Genetic sequencing to identify variants.
  • In vitro analysis of the MAX b-HLH-LZ domain protein function.
  • Assessment of c-Myc transcriptional activity.

Main Results:

  • Identified a recurrent de novo c.179G>A (p.Arg60Gln) variant in MAX in three individuals.
  • The MAX Arg60Gln mutation increases CCND2 transcription but not its stabilization.
  • The MAX Arg60Gln variant exhibits reduced binding affinity, enhancing c-Myc heterodimerization and transcriptional activity.

Conclusions:

  • The MAX Arg60Gln variant contributes to macrocephaly through increased c-Myc-driven transcription.
  • Omomyc-CPP, a c-Myc inhibitor, presents a potential therapeutic strategy for individuals with this MAX mutation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K